date,title,source
Oct-18-18,Today's Research Reports on Trending Tickers: Immunomedics and FibroGen,ACCESSWIRE
Oct-25-18,FibroGen Presents Results from Two Phase 3 Studies of Roxadustat for the Treatment of Anemia Associated with Chronic Kidney Disease Conducted in China at American Society of Nephrology Kidney Week 2018 Annual Meeting,GlobeNewswire
Oct-30-18,ASN Kidney Week 2018: Data Presented from Two Japanese Phase 3 Studies on Roxadustat in the Treatment of Anemia Associated with Chronic Kidney Disease in Patients on Dialysis,GlobeNewswire
Nov-05-18,What Kind Of Shareholder Appears On The FibroGen Incs (NASDAQ:FGEN) Shareholder Register?,Simply Wall St.
Nov-08-18,"FibroGen (FGEN) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-08-18,FibroGen: 3Q Earnings Snapshot,Associated Press
Nov-08-18,FibroGen Reports Third Quarter 2018 Financial Results,GlobeNewswire
Nov-09-18,Edited Transcript of FGEN earnings conference call or presentation 8-Nov-18 10:00pm GMT,Thomson Reuters StreetEvents
Nov-14-18,Today's Research Reports on Trending Tickers: Amicus Therapeutics and FibroGen,ACCESSWIRE
Nov-16-18,Edited Transcript of FGEN earnings conference call or presentation 8-Nov-18 10:00pm GMT,Thomson Reuters StreetEvents
Nov-27-18,"New Research Coverage Highlights Phibro Animal Health, RadNet, Amphastar Pharmaceuticals, FibroGen, Sientra, and Flexion Therapeutics  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Dec-06-18,"FibroGen Appoints Maykin Ho, Ph.D., to Board of Directors",GlobeNewswire
Dec-17-18,FibroGen Announces Approval of Roxadustat in China for the Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis,GlobeNewswire
Dec-17-18,"How Many Insiders Sold FibroGen, Inc. (NASDAQ:FGEN) Shares?",Simply Wall St.
Dec-18-18,[$$] Big Pharma Wins Drug Approval in China Ahead of West for First Time,The Wall Street Journal
Dec-18-18,Why a kidney disease drug approval in China is just the start for this S.F. company,American City Business Journals
Dec-18-18,[$$] Big Pharma Wins Drug Approval in China Ahead of West for First Time,The Wall Street Journal
Dec-18-18,"The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan",Benzinga
Dec-18-18,Today's Research Reports on Trending Tickers: Puma Biotechnology and FibroGen,ACCESSWIRE
Dec-18-18,"China first to approve AstraZeneca, FibroGen anaemia drug",Reuters
Dec-19-18,FibroGen Inc (FGEN): Hedge Fund Sentiment Unchanged,Insider Monkey
